Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Diabetic retinopathy is an eye disease that can develop in people ... As it progresses, people may experience symptoms such as: changes in vision, which may come and go, such as difficulty reading ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...

More than a million Brits could be living with undiagnosed diabetes, with early detection being key to managing the condition and maintaining a good quality of life ...

The doctor highlighted a link between increased urination and sudden weight loss as potential early indicators of diabetes, ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.